| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 96 |
| 1 | INSULIN LISPRO | 34 |
| 2 | INSULIN ASPART | 32 |
| 3 | INSULIN HUMAN | 18 |
| 4 | HUMAN INSULIN | 12 |
| 5 | INSULIN DEGLUDEC | 12 |
| 6 | INSULIN GLARGINE-YFGN | 11 |
| 7 | METFORMIN | 11 |
| 8 | FUROSEMIDE | 10 |
| 9 | OLANZAPINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN INSULIN | 12 | 0.0017 |
| 1 | BEDAQUILINE FUMARATE | 2 | 0.0014 |
| 2 | INSULIN ASPART INJECTION | 2 | 0.0007 |
| 3 | INSULIN GLULISINE | 6 | 0.0006 |
| 4 | INSULIN DEGLUDEC | 12 | 0.0005 |
| 5 | INSULIN ASPART | 32 | 0.0005 |
| 6 | INSULIN GLARGINE-YFGN | 11 | 0.0005 |
| 7 | SOFOSBUVIR | 9 | 0.0005 |
| 8 | INSULIN HUMAN | 18 | 0.0005 |
| 9 | INSULIN GLARGINE | 96 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin [EPC] | 30 | 0.0006 |
| 1 | Insulin Analog [EPC] | 145 | 0.0003 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 3 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 4 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 9 | 0.0002 |
| 6 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 8 | Antimycobacterial [EPC] | 3 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |